טוען...
Hepatitis C: Treatment of difficult to treat patients
Over the past several years, more so recently, treatment options for hepatitis C virus (HCV) have seemed to exponentially grow. Up until recently, the regimen of pegylated interferon (peg-IFN) and ribavirin (RBV) stood as the standard of care. Direct acting antivirals, which target nonstructural pro...
שמור ב:
| הוצא לאור ב: | World J Hepatol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517154/ https://ncbi.nlm.nih.gov/pubmed/26244069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i15.1953 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|